Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-29 Purchase |
2024-06-07 9:45 pm |
GENELUX Corp | GNLX | Smither John W Director |
6,250 | $0 | $0 | 19,420 (Direct) |
View |
| 2023-09-13 Sale |
2023-09-14 8:18 pm |
GENELUX Corp | GNLX | Smither John W Director |
900 | $20.78 | $18,702 | 6,920 (Direct) |
View |
| 2021-03-10 Sale |
2021-03-11 3:59 pm |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
1,750 | $32.9 | $57,575 | 178,018 (Indirect Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 4:48 pm |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
773 | $34.2 | $26,440 | 112,390 (Indirect Direct) |
View |
| 2021-02-10 Sale |
2021-02-12 5:32 pm |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
2,750 | $35.64 | $98,010 | 158,645 (Indirect Direct) |
View |
| 2021-02-01 Sale |
2021-02-03 11:23 am |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
5,000 | $35 | $175,000 | 161,395 (Indirect Direct) |
View |
| 2021-01-19 Sale |
2021-01-21 4:41 pm |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
1,750 | $30 | $52,500 | 166,395 (Indirect Direct) |
View |
| 2020-12-14 Sale |
2020-12-16 3:14 pm |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
5,250 | $30 | $157,500 | 168,145 (Indirect Direct) |
View |
| 2020-09-29 Sale |
2020-10-01 9:00 pm |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
1,750 | $30 | $52,500 | 172,072 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-06 Option Award |
2025-01-08 6:09 pm |
N/A 2035-01-06 |
NewAmsterdam Pharma Co N.V. | NAMS | Smither John W Director |
39,460 | $0 | 39,460 (Direct) |
View |
| 2024-08-01 Option Award(A) |
2024-12-31 1:20 pm |
N/A 2034-07-31 |
GENELUX Corp | GNLX | Smither John W Director |
50,469 | $0 | 50,469 (Direct) |
View |
| 2024-08-01 Option Award |
2024-08-05 6:34 pm |
N/A 2034-07-31 |
GENELUX Corp | GNLX | Smither John W Director |
90,010 | $0 | 103,180 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 6:23 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
11,365 | $0 | 152,757 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 5:13 pm |
N/A 2034-01-01 |
NewAmsterdam Pharma Co N.V. | NAMS | Smither John W Director |
10,000 | $0 | 10,000 (Direct) |
View |
Ownership |
2023-12-29 4:30 pm |
N/A 2033-01-14 |
NewAmsterdam Pharma Co N.V. | NAMS | Smither John W Director |
0 | $0 | 18,600 (Direct) |
View |
| 2023-09-11 Option Award |
2023-09-13 8:14 pm |
N/A 2033-09-10 |
GENELUX Corp | GNLX | Smither John W Director |
15,367 | $0 | 16,267 (Direct) |
View |
Ownership |
2023-09-13 8:13 pm |
N/A N/A |
GENELUX Corp | GNLX | Smither John W Director |
0 | $0 | 900 (Direct) |
View |
| 2023-08-31 Option Award |
2023-09-05 9:38 pm |
N/A 2033-08-31 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
125,000 | $0 | 125,000 (Direct) |
View |
Ownership |
2023-09-05 9:36 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
0 | $0 | 253,738 (Indirect) |
View |
| 2023-06-22 Option Award |
2023-06-22 8:16 pm |
N/A 2033-06-21 |
eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-15 5:28 pm |
N/A 2033-06-14 |
Applied Molecular Transport Inc. | AMTI | Smither John W Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-01-20 Option Award |
2023-01-24 4:15 pm |
N/A 2033-01-19 |
eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director |
36,875 | $0 | 36,875 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 6:51 pm |
N/A 2032-06-08 |
eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-26 5:23 pm |
N/A 2032-05-24 |
Applied Molecular Transport Inc. | AMTI | Smither John W Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 5:39 pm |
2022-02-27 2032-01-27 |
Applied Molecular Transport Inc. | AMTI | Smither John W Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-10-06 Option Award |
2021-10-08 5:18 pm |
N/A 2031-10-05 |
eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-08-25 Option Award |
2021-08-27 6:26 pm |
N/A 2028-03-26 |
eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director |
27,698 | $0 | 51,840 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-11 3:59 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
500 | $1.6806 | 178,018 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-11 3:59 pm |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
500 | $0 | 178,018 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-05 3:55 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
12,396 | $1.6806 | 260,770 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 3:55 pm |
N/A 2031-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
38,300 | $0 | 260,770 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-05 3:55 pm |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
12,396 | $0 | 260,770 (Direct) |
View |
| 2021-02-10 Exercise |
2021-02-12 5:32 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
750 | $1.6806 | 158,645 (Direct) |
View |
| 2021-02-10 Exercise |
2021-02-12 5:32 pm |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
750 | $0 | 158,645 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 11:23 am |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
1,250 | $1.6806 | 161,395 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 11:23 am |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
1,250 | $0 | 161,395 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-21 4:41 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
500 | $1.6806 | 166,395 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-21 4:41 pm |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
500 | $0 | 166,395 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 3:14 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
1,500 | $1.6806 | 168,145 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 3:14 pm |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
1,500 | $0 | 168,145 (Direct) |
View |
| 2020-09-29 Exercise |
2020-10-01 9:00 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
500 | $1.6806 | 172,072 (Direct) |
View |
| 2020-09-29 Exercise |
2020-10-01 9:00 pm |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
500 | $0 | 172,072 (Direct) |
View |
| 2020-06-11 Exercise |
2020-06-15 3:15 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
14,875 | $1.6806 | 233,920 (Direct) |
View |
| 2020-06-11 Exercise |
2020-06-15 3:15 pm |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
14,875 | $0 | 233,920 (Direct) |
View |